Evaluation of Raltegravir During the Third Trimester of Pregnancy
Phase 2
Completed
- Conditions
- PREGNANCYHIV-1 Infection
- Interventions
- Other: Study of pharmacokinetic properties of raltegravir during the 3rd trimester of pregnancy
- First Posted Date
- 2014-03-31
- Last Posted Date
- 2017-08-22
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 83
- Registration Number
- NCT02099474
- Locations
- 🇫🇷
CHU Hôtel Dieu, Paris, France
Assessing the Severity of Metabolic-related Liver Injuries in Aging HIV-monoinfected Patients
Not Applicable
Completed
- Conditions
- Liver InjuriesHIV Infection
- First Posted Date
- 2014-03-21
- Last Posted Date
- 2016-07-12
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 460
- Registration Number
- NCT02093754
- Locations
- 🇩🇪
Hannover Medical School, Hannover, Germany
🇩🇪Center for HIV and Hepato-Gastroenterology, Düsseldorf, Germany
🇧🇪CHU Brussels, Brussels, Belgium
Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3
Phase 4
Completed
- Conditions
- HIV-1 Infection
- Interventions
- Device: Xpert MTB/RIF®, Determine TB LAM, Chest X-rayDrug: ART (Atripla, Truvada, Efavirenz, Combivir)Drug: Rifampin, isoniazid, pyrazinamide, ethambutol
- First Posted Date
- 2014-02-07
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 1050
- Registration Number
- NCT02057796
- Locations
- 🇻🇳
Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam
🇰🇭Sihanouk Hospital Center of Hope, Phnom Penh, Cambodia
🇺🇬ISS ImmunoSuppression Service, Mbarara, Uganda
Outcome at 5 Years of Early Treated HIV Infected Infants in the PEDIACAM Project
Active, not recruiting
- Conditions
- HIV
- First Posted Date
- 2014-01-23
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 460
- Registration Number
- NCT02043418
- Locations
- 🇨🇲
Hôpital Laquintinie, Douala, Cameroon
🇨🇲Centre Hospitalier d'Essos, Yaounde, Cameroon
🇨🇲Centre Mère et Enfant de la Fondation Chantal Biya, Yaounde, Cameroon
Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers
Phase 1
Completed
- Conditions
- HIV Infection
- Interventions
- Biological: LIPO-5Biological: MVA HIV-B (MVATG17401)
- First Posted Date
- 2014-01-17
- Last Posted Date
- 2016-06-01
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 92
- Registration Number
- NCT02038842
- Locations
- 🇫🇷
Service d'Immunologie Clinique 51, avenue du Marechal de Lattre de Tassigny, Creteil, France
Third Line Antiretroviral Treatment Optimization in Sub-Saharan Africa
Phase 2
- Conditions
- HIV Infection
- Interventions
- Behavioral: adherence reinforcement
- First Posted Date
- 2014-01-01
- Last Posted Date
- 2017-02-17
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 201
- Registration Number
- NCT02025868
- Locations
- 🇧🇫
CHU Yalgado Ouedraogo, Ouagadougou, Burkina Faso
🇧🇫CHU Sourô Sanou, Bobo-Dioulasso, Burkina Faso
🇨🇮Centre de Prise en Charge et de Formation (CePReF), Association ACONDA, Abidjan, Côte D'Ivoire
Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection
Phase 2
- Conditions
- TuberculosisHIV
- Interventions
- Drug: drug administration
- First Posted Date
- 2013-11-18
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 105
- Registration Number
- NCT01986543
- Locations
- 🇺🇬
Mbarara Research Base, Mbarara PO box 1956, Mbarara, Uganda
Therapeutic Option for Hepatitis B and C: a French Cohort
Active, not recruiting
- Conditions
- Viral Hepatitis BViral Hepatitis C
- First Posted Date
- 2013-10-01
- Last Posted Date
- 2023-01-31
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 20902
- Registration Number
- NCT01953458
X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study
Not Applicable
Completed
- Conditions
- Hiv Infection
- Interventions
- Biological: A peripheral blood sample
- First Posted Date
- 2013-09-30
- Last Posted Date
- 2015-07-01
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 90
- Registration Number
- NCT01952587
- Locations
- 🇫🇷
Purpan Hospital, Toulouse, France
Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection
- Conditions
- HCV RecurrenceLiver TransplantationDirect-acting Antiviral Agents
- First Posted Date
- 2013-09-17
- Last Posted Date
- 2016-02-02
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 699
- Registration Number
- NCT01944527
- Locations
- 🇫🇷
Claire Fougerou, Rennes, France
© Copyright 2025. All Rights Reserved by MedPath